CN101049315A - 一种寻常痤疮药配方 - Google Patents
一种寻常痤疮药配方 Download PDFInfo
- Publication number
- CN101049315A CN101049315A CN 200610039479 CN200610039479A CN101049315A CN 101049315 A CN101049315 A CN 101049315A CN 200610039479 CN200610039479 CN 200610039479 CN 200610039479 A CN200610039479 A CN 200610039479A CN 101049315 A CN101049315 A CN 101049315A
- Authority
- CN
- China
- Prior art keywords
- skin
- medicine
- acne
- quickly
- acne vulgaris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 206010000496 acne Diseases 0.000 title claims abstract description 32
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 29
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 6
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001380 cimetidine Drugs 0.000 claims abstract description 6
- 229960001699 ofloxacin Drugs 0.000 claims abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 6
- 239000011593 sulfur Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 238000005457 optimization Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 239000002674 ointment Substances 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 3
- 230000004215 skin function Effects 0.000 abstract description 2
- 208000032544 Cicatrix Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 208000010201 Exanthema Diseases 0.000 abstract 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract 1
- 201000005884 exanthem Diseases 0.000 abstract 1
- 230000036074 healthy skin Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010037844 rash Diseases 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000037387 scars Effects 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000000589 cicatrix Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960005280 isotretinoin Drugs 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000003859 smegma Anatomy 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种寻常痤疮药配方为：硫黄4－5g，氧氟沙星0.5－0.75g，甲氰咪呱1－2g，维生素B60.10.2－g，纯霜80－100g制成软膏，一日2次涂患处。能消炎消肿，抑脂健肤，能够快速杀菌，能快速消疹消肿，修复被损坏的皮脂腺组织，快速恢复皮肤功能，本不易恢复所产生的面肤色素沉着、轻度瘢痕、面肤皱缩而得到恢复健康面肤，治愈率高，复发率低，在1周至4周内治好。主要用途：面部寻常痤疮，对胸背部痤疮同样快速治愈。痤疮药极少有轻微涂药局部皮肤过敏现象，但不影响治疗，亦无其他副作用，无后遗症，治疗简单，使用方便，花钱少，没有痛苦，安全可靠。
Description
1、技术领域
本发明涉及一种治疗的寻常痤疮药。
2、背景技术
寻常痤疮是由于体内性激素平衡紊乱等因素引起的皮脂腺毛囊的慢性炎症性疾病。常生于面部、胸部、肩胛间区背部等皮脂腺发达的部位。其临床特点：最早皮损位于毛囊口的粉刺或黑头粉刺，逐渐发展到整个面部，多数患者可形成丘疹、脓疱、结节、脓肿、皮损疏散分布，大多非常密集，严重的最后可形成瘢痕、色素沉着、毛孔增粗，永不消失后遗症，明显影响面部皮肤的健康和美容，结果，病未治好，还大大浪费了经济费用，增加了患者心理压力和精神上的痛苦。
寻常痤疮是临床上常见病，少数患者能在青春期过后可自愈，但多数患者，症状较重，经多方医治，得不到治愈、形成慢性病。现用药有：美满梅素、粉刺灵、乙烯雌酚片、痤疮冲剂等，内服中药汤剂，片剂、丸剂、胶囊等，外用有膏剂、水剂，口服中药汤剂、中药胶囊、中药洗剂等，以及注射针剂、封闭、冷冻、针炙等方法，是消炎、抗菌、调节内分泌代谢作用的，这些是治疗痤疮的常用主要药物，但是这些种种药品用到病人身上，大多数不起多大作用，消除不了面部痤疮症状，脓疱结节脓肿依然存在，甚至连丘疹粉刺亦消除不了，还有些患者，因用药时间过长，痤疮症状严重等原因，引起色素沉着、瘢痕等副作用、后遗症，这些在门诊上经常可见。主要存在着药物进入人体对疾病的治疗效果不太理想，见效不快，治愈率不高。
根据治疗痤疮的临床统计调查，有248人中有121人曾经在24所以上医院治疗过无效，有44人经过1所医院治疗过，77人经过2～5所医院治疗过，他们大多数采用中药、西药，内外同治等多种方法，有的用药疗程长，一般4～8周、8～12周以上，结果121名患者都未取得治愈的结果，甚至有部份患者症状加重，并产生色素沉着、瘢痕后遗症。
药品市场上对痤疮方面的药种类很多其药品名称如下：
| 城市 | 药房 | 药品名称 |
| 上海市 | 华氏大药房(上海连锁总店) | 异维A酸胶丸、维A酸乳膏、美满梅素、乙烯雌粉片、抗菌素类等 |
| 南京市 | 百姓药房 | 丹参酮胶囊、泰尔丝A酸胶丸、痤立消膏、除痘之膏、片仔癀膏、秋臣豆豆消膏、泽平粉刺立消净膏等 |
| 百姓缘药房 | 肤净可达(进口)、冰王痘克膏、冰王熏衣草痤疮平膏、痘平膏、安肤平克痤酮宁膏、玖芦消痤膏 | |
| 芝林大药房超市 | 海洋野战粉刺净、冰王痤克、痘克、粉刺七日净、新辰粉刺净 | |
| 通州市 | 仁寿药房大超市 | 异维A酸胶丸、维A酸脂E丸、维A酸乳膏等 |
3、发明内容
为了克服现有痤疮药治疗效果差的缺陷，提出一种中西药相结合寻常痤疮药配方。
配方：硫黄4-5g，氧氟沙星0.5-0.75g，甲氰咪呱1-2g，维生素B60.10.2-g，纯霜80-100g。
该方是中西结合药，能攻毒杀虫，抑脂散结，广谱抗菌杀菌型，消炎消肿，软化皮肤。抑制调节皮脂腺分泌旺盛，参与脂肪、蛋白质、糖代谢作用。
4、附图说明
无
5、具体实施方式
将硫黄4-5g，氧氟沙星0.5-0.75g，甲氰咪呱1-2g，维生素B60.10.2-g，纯霜80-100g，制成软膏，一目2次涂患处
发明的中西结合痤疮药，运用了中西医药理论相结合的治疗方法。中药硫黄为：攻毒杀虫，抑脂散结。西药：氧氟沙星、甲氰咪呱、维生素B6为：广谱抗菌——杀菌型、消炎消肿，抑制皮脂腺分泌旺盛，参与皮内的脂肪、蛋白质、糖的代谢，快速地促进恢复皮肤功能，这一技术方案的实施，将药涂在患处，大部分患者在1周至1月内治愈，少数患者1月以上全愈。同时还获得了以外的收获，有些患者因症状严重等因素，面部留下了后遗症、色素沉着、轻度瘢痕、面肤皱缩，亦很快消失、全愈。恢复到原来的健康面肤。针对现有医药技术、消除痤疮面部症状难度大这一缺陷和不足，并还以外地消除了不易消除的后遗症，获得了面部美容的效果。
中西结合痤疮膏，不管病程长短、病情轻重、年龄大小、不同性别，都能达到理想的治愈效果，多年来，进行治疗寻常痤疮248人，其中初诊患者127人，经过其他医院治疗未愈的介绍来我诊所患者121人。248人中有239人全部治愈，治愈率达96％。痤疮药对极个别患者涂药局部皮肤有轻度过敏反应，但不影响治疗，该方无其他副作用和后遗症。此药膏治疗简单，使用方便，花钱极少，安全实效。研配了中西结合药膏，经过多年的临床反复实践，已达到非常满意的临床效果，并使用方便，安全可靠，经济实效的中西结合药。
Claims (2)
1、一种寻常痤疮药配方，其特征在于配方是硫黄4-5g，氧氟沙星0.5-0.75g，甲氰咪呱1-2g，维生素B60.10.2-g，纯霜80-100g。
2、根据权利要求1一种寻常痤疮药配方，其特征在于最优配方是硫黄5g，氧氟沙星0.75g，甲氰咪呱2g，维生素B60.1g，纯霜100g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100394795A CN101049315B (zh) | 2006-04-05 | 2006-04-05 | 一种用于治疗寻常痤疮的药物组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2006100394795A CN101049315B (zh) | 2006-04-05 | 2006-04-05 | 一种用于治疗寻常痤疮的药物组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101049315A true CN101049315A (zh) | 2007-10-10 |
| CN101049315B CN101049315B (zh) | 2011-04-27 |
Family
ID=38781051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006100394795A Expired - Fee Related CN101049315B (zh) | 2006-04-05 | 2006-04-05 | 一种用于治疗寻常痤疮的药物组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101049315B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012097518A1 (zh) * | 2011-01-20 | 2012-07-26 | Ma Xuerong | 治疗痤疮的药 |
| CN103127281A (zh) * | 2011-11-22 | 2013-06-05 | 吉林省第二荣复军人医院 | 一种治疗痤疮的药物 |
| CN105998232A (zh) * | 2016-05-23 | 2016-10-12 | 四川省中医药科学院 | 马甲子或其提取物在制备治疗痤疮的药物中的用途 |
-
2006
- 2006-04-05 CN CN2006100394795A patent/CN101049315B/zh not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012097518A1 (zh) * | 2011-01-20 | 2012-07-26 | Ma Xuerong | 治疗痤疮的药 |
| CN103127281A (zh) * | 2011-11-22 | 2013-06-05 | 吉林省第二荣复军人医院 | 一种治疗痤疮的药物 |
| CN103127281B (zh) * | 2011-11-22 | 2014-12-10 | 吉林省第二荣复军人医院 | 一种治疗痤疮的药物 |
| CN105998232A (zh) * | 2016-05-23 | 2016-10-12 | 四川省中医药科学院 | 马甲子或其提取物在制备治疗痤疮的药物中的用途 |
| CN105998232B (zh) * | 2016-05-23 | 2019-12-20 | 四川省中医药科学院 | 马甲子或其提取物在制备治疗痤疮的药物中的用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101049315B (zh) | 2011-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101468070A (zh) | 一种治疗痤疮的药物组合及其制备方法 | |
| CN102247541A (zh) | 一种治疗肝肾病、糖尿病、哮喘、风湿、皮肤肿瘤的药物 | |
| CN101049315B (zh) | 一种用于治疗寻常痤疮的药物组合物 | |
| CN1583112A (zh) | 补肾壮阳胶囊 | |
| CN102552734B (zh) | 一种治疗口腔溃疡的漱口液 | |
| CN102078450A (zh) | 一种治疗青春痘的药物组合物 | |
| CN108042729A (zh) | 一种含有蒲公英根的祛痘药膏 | |
| CN101036645A (zh) | 用于治疗痤疮的药物组合物 | |
| CN1148216C (zh) | 一种治疗粉刺暗疮的药物 | |
| CN103127379A (zh) | 一种治疗雀斑的口服液 | |
| CN112891458B (zh) | 一种内含平卧菊三七的外用治疗皮肤色斑的美白祛斑精华及其制备方法和应用 | |
| CN108126008A (zh) | 迷迭香虫草丸 | |
| CN102688365B (zh) | 治疗头晕白果中药口服液及制备方法 | |
| CN108578549B (zh) | 治疗痤疮的药物及其应用 | |
| CN101337006B (zh) | 一种治疗痤疮粉刺的复合擦剂 | |
| CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
| CN104173545B (zh) | 脂溢性皮炎外用搓涂酒剂及制备方法 | |
| CN103127281B (zh) | 一种治疗痤疮的药物 | |
| Dwivedi et al. | A Review on: A promising approach towards the treatment of acne with the natural agents | |
| CN105327325A (zh) | 一种治疗白癜风的外用中药及其制备方法 | |
| CN105456658A (zh) | 一种用于除痘养颜美容的中药保健制剂 | |
| CN105770817A (zh) | 一种益气活血除湿解毒皮肤病异病同治中药组合物配方 | |
| CN117695356A (zh) | 一种祛斑祛痘中药组合物及其制备方法 | |
| CN105477036A (zh) | 一种治疗痤疮的药物及其制备方法 | |
| CN103800621A (zh) | 一种治疗前列腺肥大以及前列腺炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20140405 |